Abiopharma

🔍 Saccomano Nicholas A (Executive)

Company: OnKure Therapeutics, Inc. (OKUR)

Report Date: 2026-06-22

Detailed Transactions and Holdings:

• Sold 86 shares of Class A Common Stock at $4.3963 per share (Direct)
  Date: 2026-06-22 | Code: S | equity_swap_involved: 0 | shares_owned_after: 11,247.00 | transaction_form_type: 4 | Footnotes: F1, F2, F3

Footnotes:

• F1: These shares were automatically sold to cover tax withholding obligations in connection with the vesting of restricted stock units ("RSUs"), pursuant to the terms of the Issuer's 2023 RSU Equity Incentive Plan.
• F2: This transaction was executed in multiple trades at prices ranging from $4.27 to $4.54. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
• F3: Certain of these securities are RSUs. Each RSU represents a contingent right to receive one share of Class A Common Stock, subject to the applicable vesting schedule and conditions of each RSU.
• F4: Includes 4,000 shares acquired under the Issuer's 2024 Employee Stock Purchase Plan on May 20, 2026.